%0 Journal Article
%T Anticancer Activities and QSAR Study of Novel Agents with a Chemical Profile of Benzimidazolyl-Retrochalcone
%A Ouattara Mahama
%A Kon¨¦ Aboudramane
%A Kon¨¦ Soleymane
%A Collet Sylvain
%A Diomand¨¦ Sekou
%A Sissouma Drissa
%J Open Journal of Medicinal Chemistry
%P 113-127
%@ 2164-313X
%D 2020
%I Scientific Research Publishing
%R 10.4236/ojmc.2020.103006
%X The present pharmacochemical and modelling work focused on a benzimidazolyl-chalcone series. These previously synthesized compounds were evaluated in vitro for their anticancer activities against a panel of seven human cancer cell lines and normal fibroblasts. Among the new benzimidazole-supported chalcones, nine (9) compounds (compounds<strong> 1 - 4, 6 - 8 </strong>and compounds <strong>10</strong> and <strong>11</strong>) showed promising anticancer activities with IC<sub>50</sub>s ranging from 0.83 to 2.58 ¦ÌM. Compounds <strong>2 </strong>and <strong>6</strong> with IC<sub>50</sub>s of 0.83 and 0.86 ¦ÌM, respectively, were shown to be potent inhibitors of HCT-116 colon cancer cell proliferation. It was therefore necessary, for a development of this new series of chalcones, to establish through a QSAR study, their quantum descriptors according to the DFT calculation method and following the B3LYP/6-31+G (d,p) theory. These descriptive and predictive studies focused on the colon HCT 116 cell line which was found to be more sensitive to the anticancer action of our benzimidazolyl-retrochalcones. QSAR study showed that the electronic energy (E<sub>elec</sub>), lipophilicity (log<em>P</em>), chemical softness (<em>S</em>) and chemical hardness (<em>¦Ç</em>) of benzimidazolyl-retrochalcones play an important role in inhibiting cancer cell proliferation.
%K Retrochalcone
%K Benzimidazole
%K Anticancer Agents
%K QSAR
%K Quantum Descriptors
%K DFT Method
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=102190